Definitive Healthcare Corp. Class A Common Stock (DH)

FairStock Score: 60/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach this as a Graham-style bargain question. Definitive Healthcare provides a SaaS healthcare commercial intelligence platform. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $55.2M and net income was -$5.4M. That compares with revenue of $60.8M and net income of -$7.6M in fiscal Q2 2025, the quarter ended 2025-06-30: the loss narrowed, but sales fell. For FY2025, filed figures show revenue of $241.5M and net income of -$138.9M. FY2024 had revenue of $252.2M and net income of -$413.1M; FY2023 revenue was $251.4M and net income was -$202.4M. Four straight loss years, and the Lynch category is none because no profitable year fits. The balance sheet and returns are not comforting: FairStock's P/B is 0.72 at the 2026-10-13 close, ROE -78.37%, ROCE -1.94%, D/E 0.89, and Altman Z-Score -2.05, all pointing to financial stress. The one clear attraction is cash generation: trailing free cash flow is $28.6M, a FairStock FCF yield of 27.3% on the $104.7M market cap at the 2026-10-13 close. But a cheap cash flow multiple can be a value trap if revenue keeps shrinking and losses persist. I cannot identify a durable moat from these figures; declining revenue and heavy losses suggest the business lacks a clear protective advantage. At $0.98, the market already discounts trouble. I would require evidence of stable or growing revenue, positive net income, and a safer balance sheet before calling this a durable bargain.

In plain English: Definitive Healthcare sells software that gives healthcare companies data and insights to help them plan and sell. The business looks weak right now: sales are shrinking, and it has lost money in each of the last four years. At 98 cents a share, the stock looks very cheap compared with the cash the business produces, but the losses and falling sales make it a risky bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer